KPRX News
Archived Headlines
- EyeGate Pharmaceuticals lowers IPO deal size to $5 million and moves to OTCQB listing 02/05/15
- Week ahead: IPO market set for another surge in the health care sector with 10 IPOs 02/02/15
- Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care 01/26/15
- EyeGate Pharmaceuticals postpones $25 million IPO 10/02/14
- 11 IPOs planned for the week of September 29; 4th quarter kicks off with a $1 billion IPO 09/29/14
See more
US IPO Weekly Recap: "Breaking" news in the IPO market as most deals end down
Breaking news: Two-thirds of this week's IPOs broke issue. Last week, we noted that the recent stretch of strong...read more
EyeGate Pharmaceuticals raises $10 million in Nasdaq listing; priced at $8.50 per share
EyeGate Pharmaceuticals, a late-stage biotech developing a treatment for eye inflammation, raised $10 million by offering 1.2 million shares and warrants at $8.50. EyeGate postponed a $25 million NASDAQ IPO in late 2014 before listing on the OTCQB in...read more
Week ahead: 10 IPOs set to price during the week of July 27
The largest biotech ever to go public is on the calendar for this week, targeting a $2.2 billion valuation at IPO. Ten IPOs and two blank check companies plan to raise over $2...read more
Open the door to vision: EyeGate Pharmaceuticals sets terms for $13 million offering on the NASDAQ
EyeGate Pharmaceuticals, a late-stage biotech developing a treatment for eye inflammation, announced terms for its initial public offering of shares on the NASDAQ on Wednesday. The Waltham, MA-based company plans to raise as much as $13 million by offering...read more